Global Human Growth Hormone Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
The Human Growth Hormone Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Human Growth Hormone Drugs market size is estimated to be worth US$ 250 million in 2021 and is forecast to a readjusted size of USD 328.6 million by 2028 with a CAGR of 4.0% during review period. Prader-Willi Syndrome accounting for % of the Human Growth Hormone Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Norditropin segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Human Growth Hormone Drugs include Eli Lilly and Company (US), Ferring Holding SA (Switzerland), Genentech, Inc. (US), GeneScience Pharmaceuticals Co., Ltd. (China), and Merck KgaA (Germany), etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Human Growth Hormone Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Chapter 1, to describe Human Growth Hormone Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Human Growth Hormone Drugs, with price, sales, revenue and global market share of Human Growth Hormone Drugs from 2019 to 2022.
Chapter 3, the Human Growth Hormone Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Growth Hormone Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Human Growth Hormone Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Human Growth Hormone Drugs.
Chapter 13, 14, and 15, to describe Human Growth Hormone Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Human Growth Hormone Drugs market size is estimated to be worth US$ 250 million in 2021 and is forecast to a readjusted size of USD 328.6 million by 2028 with a CAGR of 4.0% during review period. Prader-Willi Syndrome accounting for % of the Human Growth Hormone Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Norditropin segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Human Growth Hormone Drugs include Eli Lilly and Company (US), Ferring Holding SA (Switzerland), Genentech, Inc. (US), GeneScience Pharmaceuticals Co., Ltd. (China), and Merck KgaA (Germany), etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Human Growth Hormone Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
- Norditropin
- Genotropin
- Humatrope
- Saizen
- Omnitrope - the Somatropin Biosimilar
- Somatropin Biopartners
- Prader-Willi Syndrome
- Turner Syndrome
- Short Stature Homeobox Gene
- Small for Gestational Age
- Chronic Renal Insufficiency
- Short Bowel Syndrome
- Eli Lilly and Company (US)
- Ferring Holding SA (Switzerland)
- Genentech, Inc. (US)
- GeneScience Pharmaceuticals Co., Ltd. (China)
- Merck KgaA (Germany)
- Novo Nordisk A/S (Denmark)
- Pfizer, Inc. (US)
- Sandoz International GmbH (Germany)
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Human Growth Hormone Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Human Growth Hormone Drugs, with price, sales, revenue and global market share of Human Growth Hormone Drugs from 2019 to 2022.
Chapter 3, the Human Growth Hormone Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Growth Hormone Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Human Growth Hormone Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Human Growth Hormone Drugs.
Chapter 13, 14, and 15, to describe Human Growth Hormone Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 MARKET OVERVIEW
1.1 Human Growth Hormone Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Human Growth Hormone Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Norditropin
1.2.3 Genotropin
1.2.4 Humatrope
1.2.5 Saizen
1.2.6 Omnitrope - the Somatropin Biosimilar
1.2.7 Somatropin Biopartners
1.3 Market Analysis by Application
1.3.1 Overview: Global Human Growth Hormone Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Prader-Willi Syndrome
1.3.3 Turner Syndrome
1.3.4 Short Stature Homeobox Gene
1.3.5 Small for Gestational Age
1.3.6 Chronic Renal Insufficiency
1.3.7 Short Bowel Syndrome
1.4 Global Human Growth Hormone Drugs Market Size & Forecast
1.4.1 Global Human Growth Hormone Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Human Growth Hormone Drugs Sales in Volume (2017-2028)
1.4.3 Global Human Growth Hormone Drugs Price (2017-2028)
1.5 Global Human Growth Hormone Drugs Production Capacity Analysis
1.5.1 Global Human Growth Hormone Drugs Total Production Capacity (2017-2028)
1.5.2 Global Human Growth Hormone Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Human Growth Hormone Drugs Market Drivers
1.6.2 Human Growth Hormone Drugs Market Restraints
1.6.3 Human Growth Hormone Drugs Trends Analysis
2 MANUFACTURERS PROFILES
2.1 Eli Lilly and Company (US)
2.1.1 Eli Lilly and Company (US) Details
2.1.2 Eli Lilly and Company (US) Major Business
2.1.3 Eli Lilly and Company (US) Human Growth Hormone Drugs Product and Services
2.1.4 Eli Lilly and Company (US) Human Growth Hormone Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Ferring Holding SA (Switzerland)
2.2.1 Ferring Holding SA (Switzerland) Details
2.2.2 Ferring Holding SA (Switzerland) Major Business
2.2.3 Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Product and Services
2.2.4 Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Genentech, Inc. (US)
2.3.1 Genentech, Inc. (US) Details
2.3.2 Genentech, Inc. (US) Major Business
2.3.3 Genentech, Inc. (US) Human Growth Hormone Drugs Product and Services
2.3.4 Genentech, Inc. (US) Human Growth Hormone Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 GeneScience Pharmaceuticals Co., Ltd. (China)
2.4.1 GeneScience Pharmaceuticals Co., Ltd. (China) Details
2.4.2 GeneScience Pharmaceuticals Co., Ltd. (China) Major Business
2.4.3 GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Product and Services
2.4.4 GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Merck KgaA (Germany)
2.5.1 Merck KgaA (Germany) Details
2.5.2 Merck KgaA (Germany) Major Business
2.5.3 Merck KgaA (Germany) Human Growth Hormone Drugs Product and Services
2.5.4 Merck KgaA (Germany) Human Growth Hormone Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Novo Nordisk A/S (Denmark)
2.6.1 Novo Nordisk A/S (Denmark) Details
2.6.2 Novo Nordisk A/S (Denmark) Major Business
2.6.3 Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Product and Services
2.6.4 Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Pfizer, Inc. (US)
2.7.1 Pfizer, Inc. (US) Details
2.7.2 Pfizer, Inc. (US) Major Business
2.7.3 Pfizer, Inc. (US) Human Growth Hormone Drugs Product and Services
2.7.4 Pfizer, Inc. (US) Human Growth Hormone Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Sandoz International GmbH (Germany)
2.8.1 Sandoz International GmbH (Germany) Details
2.8.2 Sandoz International GmbH (Germany) Major Business
2.8.3 Sandoz International GmbH (Germany) Human Growth Hormone Drugs Product and Services
2.8.4 Sandoz International GmbH (Germany) Human Growth Hormone Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 HUMAN GROWTH HORMONE DRUGS BREAKDOWN DATA BY MANUFACTURER
3.1 Global Human Growth Hormone Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Human Growth Hormone Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Human Growth Hormone Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Human Growth Hormone Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Human Growth Hormone Drugs Manufacturer Market Share in 2021
3.5 Global Human Growth Hormone Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Human Growth Hormone Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 MARKET ANALYSIS BY REGION
4.1 Global Human Growth Hormone Drugs Market Size by Region
4.1.1 Global Human Growth Hormone Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Human Growth Hormone Drugs Revenue by Region (2017-2028)
4.2 North America Human Growth Hormone Drugs Revenue (2017-2028)
4.3 Europe Human Growth Hormone Drugs Revenue (2017-2028)
4.4 Asia-Pacific Human Growth Hormone Drugs Revenue (2017-2028)
4.5 South America Human Growth Hormone Drugs Revenue (2017-2028)
4.6 Middle East and Africa Human Growth Hormone Drugs Revenue (2017-2028)
5 MARKET SEGMENT BY TYPE
5.1 Global Human Growth Hormone Drugs Sales in Volume by Type (2017-2028)
5.2 Global Human Growth Hormone Drugs Revenue by Type (2017-2028)
5.3 Global Human Growth Hormone Drugs Price by Type (2017-2028)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Human Growth Hormone Drugs Sales in Volume by Application (2017-2028)
6.2 Global Human Growth Hormone Drugs Revenue by Application (2017-2028)
6.3 Global Human Growth Hormone Drugs Price by Application (2017-2028)
7 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
7.1 North America Human Growth Hormone Drugs Sales by Type (2017-2028)
7.2 North America Human Growth Hormone Drugs Sales by Application (2017-2028)
7.3 North America Human Growth Hormone Drugs Market Size by Country
7.3.1 North America Human Growth Hormone Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Human Growth Hormone Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION
8.1 Europe Human Growth Hormone Drugs Sales by Type (2017-2028)
8.2 Europe Human Growth Hormone Drugs Sales by Application (2017-2028)
8.3 Europe Human Growth Hormone Drugs Market Size by Country
8.3.1 Europe Human Growth Hormone Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Human Growth Hormone Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION
9.1 Asia-Pacific Human Growth Hormone Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Human Growth Hormone Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Human Growth Hormone Drugs Market Size by Region
9.3.1 Asia-Pacific Human Growth Hormone Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Human Growth Hormone Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 SOUTH AMERICA BY REGION, BY TYPE, AND BY APPLICATION
10.1 South America Human Growth Hormone Drugs Sales by Type (2017-2028)
10.2 South America Human Growth Hormone Drugs Sales by Application (2017-2028)
10.3 South America Human Growth Hormone Drugs Market Size by Country
10.3.1 South America Human Growth Hormone Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Human Growth Hormone Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION
11.1 Middle East & Africa Human Growth Hormone Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Human Growth Hormone Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Human Growth Hormone Drugs Market Size by Country
11.3.1 Middle East & Africa Human Growth Hormone Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Human Growth Hormone Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 RAW MATERIAL AND INDUSTRY CHAIN
12.1 Raw Material of Human Growth Hormone Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Human Growth Hormone Drugs
12.3 Human Growth Hormone Drugs Production Process
12.4 Human Growth Hormone Drugs Industrial Chain
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Human Growth Hormone Drugs Typical Distributors
13.3 Human Growth Hormone Drugs Typical Customers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
1.1 Human Growth Hormone Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Human Growth Hormone Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Norditropin
1.2.3 Genotropin
1.2.4 Humatrope
1.2.5 Saizen
1.2.6 Omnitrope - the Somatropin Biosimilar
1.2.7 Somatropin Biopartners
1.3 Market Analysis by Application
1.3.1 Overview: Global Human Growth Hormone Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Prader-Willi Syndrome
1.3.3 Turner Syndrome
1.3.4 Short Stature Homeobox Gene
1.3.5 Small for Gestational Age
1.3.6 Chronic Renal Insufficiency
1.3.7 Short Bowel Syndrome
1.4 Global Human Growth Hormone Drugs Market Size & Forecast
1.4.1 Global Human Growth Hormone Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Human Growth Hormone Drugs Sales in Volume (2017-2028)
1.4.3 Global Human Growth Hormone Drugs Price (2017-2028)
1.5 Global Human Growth Hormone Drugs Production Capacity Analysis
1.5.1 Global Human Growth Hormone Drugs Total Production Capacity (2017-2028)
1.5.2 Global Human Growth Hormone Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Human Growth Hormone Drugs Market Drivers
1.6.2 Human Growth Hormone Drugs Market Restraints
1.6.3 Human Growth Hormone Drugs Trends Analysis
2 MANUFACTURERS PROFILES
2.1 Eli Lilly and Company (US)
2.1.1 Eli Lilly and Company (US) Details
2.1.2 Eli Lilly and Company (US) Major Business
2.1.3 Eli Lilly and Company (US) Human Growth Hormone Drugs Product and Services
2.1.4 Eli Lilly and Company (US) Human Growth Hormone Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Ferring Holding SA (Switzerland)
2.2.1 Ferring Holding SA (Switzerland) Details
2.2.2 Ferring Holding SA (Switzerland) Major Business
2.2.3 Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Product and Services
2.2.4 Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Genentech, Inc. (US)
2.3.1 Genentech, Inc. (US) Details
2.3.2 Genentech, Inc. (US) Major Business
2.3.3 Genentech, Inc. (US) Human Growth Hormone Drugs Product and Services
2.3.4 Genentech, Inc. (US) Human Growth Hormone Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 GeneScience Pharmaceuticals Co., Ltd. (China)
2.4.1 GeneScience Pharmaceuticals Co., Ltd. (China) Details
2.4.2 GeneScience Pharmaceuticals Co., Ltd. (China) Major Business
2.4.3 GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Product and Services
2.4.4 GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Merck KgaA (Germany)
2.5.1 Merck KgaA (Germany) Details
2.5.2 Merck KgaA (Germany) Major Business
2.5.3 Merck KgaA (Germany) Human Growth Hormone Drugs Product and Services
2.5.4 Merck KgaA (Germany) Human Growth Hormone Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Novo Nordisk A/S (Denmark)
2.6.1 Novo Nordisk A/S (Denmark) Details
2.6.2 Novo Nordisk A/S (Denmark) Major Business
2.6.3 Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Product and Services
2.6.4 Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Pfizer, Inc. (US)
2.7.1 Pfizer, Inc. (US) Details
2.7.2 Pfizer, Inc. (US) Major Business
2.7.3 Pfizer, Inc. (US) Human Growth Hormone Drugs Product and Services
2.7.4 Pfizer, Inc. (US) Human Growth Hormone Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Sandoz International GmbH (Germany)
2.8.1 Sandoz International GmbH (Germany) Details
2.8.2 Sandoz International GmbH (Germany) Major Business
2.8.3 Sandoz International GmbH (Germany) Human Growth Hormone Drugs Product and Services
2.8.4 Sandoz International GmbH (Germany) Human Growth Hormone Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 HUMAN GROWTH HORMONE DRUGS BREAKDOWN DATA BY MANUFACTURER
3.1 Global Human Growth Hormone Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Human Growth Hormone Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Human Growth Hormone Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Human Growth Hormone Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Human Growth Hormone Drugs Manufacturer Market Share in 2021
3.5 Global Human Growth Hormone Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Human Growth Hormone Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 MARKET ANALYSIS BY REGION
4.1 Global Human Growth Hormone Drugs Market Size by Region
4.1.1 Global Human Growth Hormone Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Human Growth Hormone Drugs Revenue by Region (2017-2028)
4.2 North America Human Growth Hormone Drugs Revenue (2017-2028)
4.3 Europe Human Growth Hormone Drugs Revenue (2017-2028)
4.4 Asia-Pacific Human Growth Hormone Drugs Revenue (2017-2028)
4.5 South America Human Growth Hormone Drugs Revenue (2017-2028)
4.6 Middle East and Africa Human Growth Hormone Drugs Revenue (2017-2028)
5 MARKET SEGMENT BY TYPE
5.1 Global Human Growth Hormone Drugs Sales in Volume by Type (2017-2028)
5.2 Global Human Growth Hormone Drugs Revenue by Type (2017-2028)
5.3 Global Human Growth Hormone Drugs Price by Type (2017-2028)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Human Growth Hormone Drugs Sales in Volume by Application (2017-2028)
6.2 Global Human Growth Hormone Drugs Revenue by Application (2017-2028)
6.3 Global Human Growth Hormone Drugs Price by Application (2017-2028)
7 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
7.1 North America Human Growth Hormone Drugs Sales by Type (2017-2028)
7.2 North America Human Growth Hormone Drugs Sales by Application (2017-2028)
7.3 North America Human Growth Hormone Drugs Market Size by Country
7.3.1 North America Human Growth Hormone Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Human Growth Hormone Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION
8.1 Europe Human Growth Hormone Drugs Sales by Type (2017-2028)
8.2 Europe Human Growth Hormone Drugs Sales by Application (2017-2028)
8.3 Europe Human Growth Hormone Drugs Market Size by Country
8.3.1 Europe Human Growth Hormone Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Human Growth Hormone Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION
9.1 Asia-Pacific Human Growth Hormone Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Human Growth Hormone Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Human Growth Hormone Drugs Market Size by Region
9.3.1 Asia-Pacific Human Growth Hormone Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Human Growth Hormone Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 SOUTH AMERICA BY REGION, BY TYPE, AND BY APPLICATION
10.1 South America Human Growth Hormone Drugs Sales by Type (2017-2028)
10.2 South America Human Growth Hormone Drugs Sales by Application (2017-2028)
10.3 South America Human Growth Hormone Drugs Market Size by Country
10.3.1 South America Human Growth Hormone Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Human Growth Hormone Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION
11.1 Middle East & Africa Human Growth Hormone Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Human Growth Hormone Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Human Growth Hormone Drugs Market Size by Country
11.3.1 Middle East & Africa Human Growth Hormone Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Human Growth Hormone Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 RAW MATERIAL AND INDUSTRY CHAIN
12.1 Raw Material of Human Growth Hormone Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Human Growth Hormone Drugs
12.3 Human Growth Hormone Drugs Production Process
12.4 Human Growth Hormone Drugs Industrial Chain
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Human Growth Hormone Drugs Typical Distributors
13.3 Human Growth Hormone Drugs Typical Customers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
LIST OF TABLES
Table 1. Global Human Growth Hormone Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Human Growth Hormone Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Eli Lilly and Company (US) Basic Information, Manufacturing Base and Competitors
Table 4. Eli Lilly and Company (US) Major Business
Table 5. Eli Lilly and Company (US) Human Growth Hormone Drugs Product and Services
Table 6. Eli Lilly and Company (US) Human Growth Hormone Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Ferring Holding SA (Switzerland) Basic Information, Manufacturing Base and Competitors
Table 8. Ferring Holding SA (Switzerland) Major Business
Table 9. Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Product and Services
Table 10. Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Genentech, Inc. (US) Basic Information, Manufacturing Base and Competitors
Table 12. Genentech, Inc. (US) Major Business
Table 13. Genentech, Inc. (US) Human Growth Hormone Drugs Product and Services
Table 14. Genentech, Inc. (US) Human Growth Hormone Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. GeneScience Pharmaceuticals Co., Ltd. (China) Basic Information, Manufacturing Base and Competitors
Table 16. GeneScience Pharmaceuticals Co., Ltd. (China) Major Business
Table 17. GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Product and Services
Table 18. GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Merck KgaA (Germany) Basic Information, Manufacturing Base and Competitors
Table 20. Merck KgaA (Germany) Major Business
Table 21. Merck KgaA (Germany) Human Growth Hormone Drugs Product and Services
Table 22. Merck KgaA (Germany) Human Growth Hormone Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Novo Nordisk A/S (Denmark) Basic Information, Manufacturing Base and Competitors
Table 24. Novo Nordisk A/S (Denmark) Major Business
Table 25. Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Product and Services
Table 26. Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Pfizer, Inc. (US) Basic Information, Manufacturing Base and Competitors
Table 28. Pfizer, Inc. (US) Major Business
Table 29. Pfizer, Inc. (US) Human Growth Hormone Drugs Product and Services
Table 30. Pfizer, Inc. (US) Human Growth Hormone Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Sandoz International GmbH (Germany) Basic Information, Manufacturing Base and Competitors
Table 32. Sandoz International GmbH (Germany) Major Business
Table 33. Sandoz International GmbH (Germany) Human Growth Hormone Drugs Product and Services
Table 34. Sandoz International GmbH (Germany) Human Growth Hormone Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Global Human Growth Hormone Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Pcs)
Table 36. Global Human Growth Hormone Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 37. Market Position of Manufacturers in Human Growth Hormone Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 38. Global Human Growth Hormone Drugs Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 39. Head Office and Human Growth Hormone Drugs Production Site of Key Manufacturer
Table 40. Human Growth Hormone Drugs New Entrant and Capacity Expansion Plans
Table 41. Human Growth Hormone Drugs Mergers & Acquisitions in the Past Five Years
Table 42. Global Human Growth Hormone Drugs Sales by Region (2017-2022) & (K Pcs)
Table 43. Global Human Growth Hormone Drugs Sales by Region (2023-2028) & (K Pcs)
Table 44. Global Human Growth Hormone Drugs Revenue by Region (2017-2022) & (USD Million)
Table 45. Global Human Growth Hormone Drugs Revenue by Region (2023-2028) & (USD Million)
Table 46. Global Human Growth Hormone Drugs Sales by Type (2017-2022) & (K Pcs)
Table 47. Global Human Growth Hormone Drugs Sales by Type (2023-2028) & (K Pcs)
Table 48. Global Human Growth Hormone Drugs Revenue by Type (2017-2022) & (USD Million)
Table 49. Global Human Growth Hormone Drugs Revenue by Type (2023-2028) & (USD Million)
Table 50. Global Human Growth Hormone Drugs Price by Type (2017-2022) & (USD/Pcs)
Table 51. Global Human Growth Hormone Drugs Price by Type (2023-2028) & (USD/Pcs)
Table 52. Global Human Growth Hormone Drugs Sales by Application (2017-2022) & (K Pcs)
Table 53. Global Human Growth Hormone Drugs Sales by Application (2023-2028) & (K Pcs)
Table 54. Global Human Growth Hormone Drugs Revenue by Application (2017-2022) & (USD Million)
Table 55. Global Human Growth Hormone Drugs Revenue by Application (2023-2028) & (USD Million)
Table 56. Global Human Growth Hormone Drugs Price by Application (2017-2022) & (USD/Pcs)
Table 57. Global Human Growth Hormone Drugs Price by Application (2023-2028) & (USD/Pcs)
Table 58. North America Human Growth Hormone Drugs Sales by Country (2017-2022) & (K Pcs)
Table 59. North America Human Growth Hormone Drugs Sales by Country (2023-2028) & (K Pcs)
Table 60. North America Human Growth Hormone Drugs Revenue by Country (2017-2022) & (USD Million)
Table 61. North America Human Growth Hormone Drugs Revenue by Country (2023-2028) & (USD Million)
Table 62. North America Human Growth Hormone Drugs Sales by Type (2017-2022) & (K Pcs)
Table 63. North America Human Growth Hormone Drugs Sales by Type (2023-2028) & (K Pcs)
Table 64. North America Human Growth Hormone Drugs Sales by Application (2017-2022) & (K Pcs)
Table 65. North America Human Growth Hormone Drugs Sales by Application (2023-2028) & (K Pcs)
Table 66. Europe Human Growth Hormone Drugs Sales by Country (2017-2022) & (K Pcs)
Table 67. Europe Human Growth Hormone Drugs Sales by Country (2023-2028) & (K Pcs)
Table 68. Europe Human Growth Hormone Drugs Revenue by Country (2017-2022) & (USD Million)
Table 69. Europe Human Growth Hormone Drugs Revenue by Country (2023-2028) & (USD Million)
Table 70. Europe Human Growth Hormone Drugs Sales by Type (2017-2022) & (K Pcs)
Table 71. Europe Human Growth Hormone Drugs Sales by Type (2023-2028) & (K Pcs)
Table 72. Europe Human Growth Hormone Drugs Sales by Application (2017-2022) & (K Pcs)
Table 73. Europe Human Growth Hormone Drugs Sales by Application (2023-2028) & (K Pcs)
Table 74. Asia-Pacific Human Growth Hormone Drugs Sales by Region (2017-2022) & (K Pcs)
Table 75. Asia-Pacific Human Growth Hormone Drugs Sales by Region (2023-2028) & (K Pcs)
Table 76. Asia-Pacific Human Growth Hormone Drugs Revenue by Region (2017-2022) & (USD Million)
Table 77. Asia-Pacific Human Growth Hormone Drugs Revenue by Region (2023-2028) & (USD Million)
Table 78. Asia-Pacific Human Growth Hormone Drugs Sales by Type (2017-2022) & (K Pcs)
Table 79. Asia-Pacific Human Growth Hormone Drugs Sales by Type (2023-2028) & (K Pcs)
Table 80. Asia-Pacific Human Growth Hormone Drugs Sales by Application (2017-2022) & (K Pcs)
Table 81. Asia-Pacific Human Growth Hormone Drugs Sales by Application (2023-2028) & (K Pcs)
Table 82. South America Human Growth Hormone Drugs Sales by Country (2017-2022) & (K Pcs)
Table 83. South America Human Growth Hormone Drugs Sales by Country (2023-2028) & (K Pcs)
Table 84. South America Human Growth Hormone Drugs Revenue by Country (2017-2022) & (USD Million)
Table 85. South America Human Growth Hormone Drugs Revenue by Country (2023-2028) & (USD Million)
Table 86. South America Human Growth Hormone Drugs Sales by Type (2017-2022) & (K Pcs)
Table 87. South America Human Growth Hormone Drugs Sales by Type (2023-2028) & (K Pcs)
Table 88. South America Human Growth Hormone Drugs Sales by Application (2017-2022) & (K Pcs)
Table 89. South America Human Growth Hormone Drugs Sales by Application (2023-2028) & (K Pcs)
Table 90. Middle East & Africa Human Growth Hormone Drugs Sales by Region (2017-2022) & (K Pcs)
Table 91. Middle East & Africa Human Growth Hormone Drugs Sales by Region (2023-2028) & (K Pcs)
Table 92. Middle East & Africa Human Growth Hormone Drugs Revenue by Region (2017-2022) & (USD Million)
Table 93. Middle East & Africa Human Growth Hormone Drugs Revenue by Region (2023-2028) & (USD Million)
Table 94. Middle East & Africa Human Growth Hormone Drugs Sales by Type (2017-2022) & (K Pcs)
Table 95. Middle East & Africa Human Growth Hormone Drugs Sales by Type (2023-2028) & (K Pcs)
Table 96. Middle East & Africa Human Growth Hormone Drugs Sales by Application (2017-2022) & (K Pcs)
Table 97. Middle East & Africa Human Growth Hormone Drugs Sales by Application (2023-2028) & (K Pcs)
Table 98. Human Growth Hormone Drugs Raw Material
Table 99. Key Manufacturers of Human Growth Hormone Drugs Raw Materials
Table 100. Direct Channel Pros & Cons
Table 101. Indirect Channel Pros & Cons
Table 102. Human Growth Hormone Drugs Typical Distributors
Table 103. Human Growth Hormone Drugs Typical Customers
Table 1. Global Human Growth Hormone Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Human Growth Hormone Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Eli Lilly and Company (US) Basic Information, Manufacturing Base and Competitors
Table 4. Eli Lilly and Company (US) Major Business
Table 5. Eli Lilly and Company (US) Human Growth Hormone Drugs Product and Services
Table 6. Eli Lilly and Company (US) Human Growth Hormone Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Ferring Holding SA (Switzerland) Basic Information, Manufacturing Base and Competitors
Table 8. Ferring Holding SA (Switzerland) Major Business
Table 9. Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Product and Services
Table 10. Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Genentech, Inc. (US) Basic Information, Manufacturing Base and Competitors
Table 12. Genentech, Inc. (US) Major Business
Table 13. Genentech, Inc. (US) Human Growth Hormone Drugs Product and Services
Table 14. Genentech, Inc. (US) Human Growth Hormone Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. GeneScience Pharmaceuticals Co., Ltd. (China) Basic Information, Manufacturing Base and Competitors
Table 16. GeneScience Pharmaceuticals Co., Ltd. (China) Major Business
Table 17. GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Product and Services
Table 18. GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Merck KgaA (Germany) Basic Information, Manufacturing Base and Competitors
Table 20. Merck KgaA (Germany) Major Business
Table 21. Merck KgaA (Germany) Human Growth Hormone Drugs Product and Services
Table 22. Merck KgaA (Germany) Human Growth Hormone Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Novo Nordisk A/S (Denmark) Basic Information, Manufacturing Base and Competitors
Table 24. Novo Nordisk A/S (Denmark) Major Business
Table 25. Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Product and Services
Table 26. Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Pfizer, Inc. (US) Basic Information, Manufacturing Base and Competitors
Table 28. Pfizer, Inc. (US) Major Business
Table 29. Pfizer, Inc. (US) Human Growth Hormone Drugs Product and Services
Table 30. Pfizer, Inc. (US) Human Growth Hormone Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Sandoz International GmbH (Germany) Basic Information, Manufacturing Base and Competitors
Table 32. Sandoz International GmbH (Germany) Major Business
Table 33. Sandoz International GmbH (Germany) Human Growth Hormone Drugs Product and Services
Table 34. Sandoz International GmbH (Germany) Human Growth Hormone Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Global Human Growth Hormone Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Pcs)
Table 36. Global Human Growth Hormone Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 37. Market Position of Manufacturers in Human Growth Hormone Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 38. Global Human Growth Hormone Drugs Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 39. Head Office and Human Growth Hormone Drugs Production Site of Key Manufacturer
Table 40. Human Growth Hormone Drugs New Entrant and Capacity Expansion Plans
Table 41. Human Growth Hormone Drugs Mergers & Acquisitions in the Past Five Years
Table 42. Global Human Growth Hormone Drugs Sales by Region (2017-2022) & (K Pcs)
Table 43. Global Human Growth Hormone Drugs Sales by Region (2023-2028) & (K Pcs)
Table 44. Global Human Growth Hormone Drugs Revenue by Region (2017-2022) & (USD Million)
Table 45. Global Human Growth Hormone Drugs Revenue by Region (2023-2028) & (USD Million)
Table 46. Global Human Growth Hormone Drugs Sales by Type (2017-2022) & (K Pcs)
Table 47. Global Human Growth Hormone Drugs Sales by Type (2023-2028) & (K Pcs)
Table 48. Global Human Growth Hormone Drugs Revenue by Type (2017-2022) & (USD Million)
Table 49. Global Human Growth Hormone Drugs Revenue by Type (2023-2028) & (USD Million)
Table 50. Global Human Growth Hormone Drugs Price by Type (2017-2022) & (USD/Pcs)
Table 51. Global Human Growth Hormone Drugs Price by Type (2023-2028) & (USD/Pcs)
Table 52. Global Human Growth Hormone Drugs Sales by Application (2017-2022) & (K Pcs)
Table 53. Global Human Growth Hormone Drugs Sales by Application (2023-2028) & (K Pcs)
Table 54. Global Human Growth Hormone Drugs Revenue by Application (2017-2022) & (USD Million)
Table 55. Global Human Growth Hormone Drugs Revenue by Application (2023-2028) & (USD Million)
Table 56. Global Human Growth Hormone Drugs Price by Application (2017-2022) & (USD/Pcs)
Table 57. Global Human Growth Hormone Drugs Price by Application (2023-2028) & (USD/Pcs)
Table 58. North America Human Growth Hormone Drugs Sales by Country (2017-2022) & (K Pcs)
Table 59. North America Human Growth Hormone Drugs Sales by Country (2023-2028) & (K Pcs)
Table 60. North America Human Growth Hormone Drugs Revenue by Country (2017-2022) & (USD Million)
Table 61. North America Human Growth Hormone Drugs Revenue by Country (2023-2028) & (USD Million)
Table 62. North America Human Growth Hormone Drugs Sales by Type (2017-2022) & (K Pcs)
Table 63. North America Human Growth Hormone Drugs Sales by Type (2023-2028) & (K Pcs)
Table 64. North America Human Growth Hormone Drugs Sales by Application (2017-2022) & (K Pcs)
Table 65. North America Human Growth Hormone Drugs Sales by Application (2023-2028) & (K Pcs)
Table 66. Europe Human Growth Hormone Drugs Sales by Country (2017-2022) & (K Pcs)
Table 67. Europe Human Growth Hormone Drugs Sales by Country (2023-2028) & (K Pcs)
Table 68. Europe Human Growth Hormone Drugs Revenue by Country (2017-2022) & (USD Million)
Table 69. Europe Human Growth Hormone Drugs Revenue by Country (2023-2028) & (USD Million)
Table 70. Europe Human Growth Hormone Drugs Sales by Type (2017-2022) & (K Pcs)
Table 71. Europe Human Growth Hormone Drugs Sales by Type (2023-2028) & (K Pcs)
Table 72. Europe Human Growth Hormone Drugs Sales by Application (2017-2022) & (K Pcs)
Table 73. Europe Human Growth Hormone Drugs Sales by Application (2023-2028) & (K Pcs)
Table 74. Asia-Pacific Human Growth Hormone Drugs Sales by Region (2017-2022) & (K Pcs)
Table 75. Asia-Pacific Human Growth Hormone Drugs Sales by Region (2023-2028) & (K Pcs)
Table 76. Asia-Pacific Human Growth Hormone Drugs Revenue by Region (2017-2022) & (USD Million)
Table 77. Asia-Pacific Human Growth Hormone Drugs Revenue by Region (2023-2028) & (USD Million)
Table 78. Asia-Pacific Human Growth Hormone Drugs Sales by Type (2017-2022) & (K Pcs)
Table 79. Asia-Pacific Human Growth Hormone Drugs Sales by Type (2023-2028) & (K Pcs)
Table 80. Asia-Pacific Human Growth Hormone Drugs Sales by Application (2017-2022) & (K Pcs)
Table 81. Asia-Pacific Human Growth Hormone Drugs Sales by Application (2023-2028) & (K Pcs)
Table 82. South America Human Growth Hormone Drugs Sales by Country (2017-2022) & (K Pcs)
Table 83. South America Human Growth Hormone Drugs Sales by Country (2023-2028) & (K Pcs)
Table 84. South America Human Growth Hormone Drugs Revenue by Country (2017-2022) & (USD Million)
Table 85. South America Human Growth Hormone Drugs Revenue by Country (2023-2028) & (USD Million)
Table 86. South America Human Growth Hormone Drugs Sales by Type (2017-2022) & (K Pcs)
Table 87. South America Human Growth Hormone Drugs Sales by Type (2023-2028) & (K Pcs)
Table 88. South America Human Growth Hormone Drugs Sales by Application (2017-2022) & (K Pcs)
Table 89. South America Human Growth Hormone Drugs Sales by Application (2023-2028) & (K Pcs)
Table 90. Middle East & Africa Human Growth Hormone Drugs Sales by Region (2017-2022) & (K Pcs)
Table 91. Middle East & Africa Human Growth Hormone Drugs Sales by Region (2023-2028) & (K Pcs)
Table 92. Middle East & Africa Human Growth Hormone Drugs Revenue by Region (2017-2022) & (USD Million)
Table 93. Middle East & Africa Human Growth Hormone Drugs Revenue by Region (2023-2028) & (USD Million)
Table 94. Middle East & Africa Human Growth Hormone Drugs Sales by Type (2017-2022) & (K Pcs)
Table 95. Middle East & Africa Human Growth Hormone Drugs Sales by Type (2023-2028) & (K Pcs)
Table 96. Middle East & Africa Human Growth Hormone Drugs Sales by Application (2017-2022) & (K Pcs)
Table 97. Middle East & Africa Human Growth Hormone Drugs Sales by Application (2023-2028) & (K Pcs)
Table 98. Human Growth Hormone Drugs Raw Material
Table 99. Key Manufacturers of Human Growth Hormone Drugs Raw Materials
Table 100. Direct Channel Pros & Cons
Table 101. Indirect Channel Pros & Cons
Table 102. Human Growth Hormone Drugs Typical Distributors
Table 103. Human Growth Hormone Drugs Typical Customers
LIST OF FIGURES
Figure 1. Human Growth Hormone Drugs Picture
Figure 2. Global Human Growth Hormone Drugs Revenue Market Share by Type in 2021
Figure 3. Norditropin
Figure 4. Genotropin
Figure 5. Humatrope
Figure 6. Saizen
Figure 7. Omnitrope - the Somatropin Biosimilar
Figure 8. Somatropin Biopartners
Figure 9. Global Human Growth Hormone Drugs Revenue Market Share by Application in 2021
Figure 10. Prader-Willi Syndrome
Figure 11. Turner Syndrome
Figure 12. Short Stature Homeobox Gene
Figure 13. Small for Gestational Age
Figure 14. Chronic Renal Insufficiency
Figure 15. Short Bowel Syndrome
Figure 16. Global Human Growth Hormone Drugs Revenue, (USD Million) & (K Pcs): 2017 & 2021 & 2028
Figure 17. Global Human Growth Hormone Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 18. Global Human Growth Hormone Drugs Sales (2017-2028) & (K Pcs)
Figure 19. Global Human Growth Hormone Drugs Price (2017-2028) & (USD/Pcs)
Figure 20. Global Human Growth Hormone Drugs Production Capacity (2017-2028) & (K Pcs)
Figure 21. Global Human Growth Hormone Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 22. Human Growth Hormone Drugs Market Drivers
Figure 23. Human Growth Hormone Drugs Market Restraints
Figure 24. Human Growth Hormone Drugs Market Trends
Figure 25. Global Human Growth Hormone Drugs Sales Market Share by Manufacturer in 2021
Figure 26. Global Human Growth Hormone Drugs Revenue Market Share by Manufacturer in 2021
Figure 27. Human Growth Hormone Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 28. Top 3 Human Growth Hormone Drugs Manufacturer (Revenue) Market Share in 2021
Figure 29. Top 6 Human Growth Hormone Drugs Manufacturer (Revenue) Market Share in 2021
Figure 30. Global Human Growth Hormone Drugs Sales Market Share by Region (2017-2028)
Figure 31. Global Human Growth Hormone Drugs Revenue Market Share by Region (2017-2028)
Figure 32. North America Human Growth Hormone Drugs Revenue (2017-2028) & (USD Million)
Figure 33. Europe Human Growth Hormone Drugs Revenue (2017-2028) & (USD Million)
Figure 34. Asia-Pacific Human Growth Hormone Drugs Revenue (2017-2028) & (USD Million)
Figure 35. South America Human Growth Hormone Drugs Revenue (2017-2028) & (USD Million)
Figure 36. Middle East & Africa Human Growth Hormone Drugs Revenue (2017-2028) & (USD Million)
Figure 37. Global Human Growth Hormone Drugs Sales Market Share by Type (2017-2028)
Figure 38. Global Human Growth Hormone Drugs Revenue Market Share by Type (2017-2028)
Figure 39. Global Human Growth Hormone Drugs Price by Type (2017-2028) & (USD/Pcs)
Figure 40. Global Human Growth Hormone Drugs Sales Market Share by Application (2017-2028)
Figure 41. Global Human Growth Hormone Drugs Revenue Market Share by Application (2017-2028)
Figure 42. Global Human Growth Hormone Drugs Price by Application (2017-2028) & (USD/Pcs)
Figure 43. North America Human Growth Hormone Drugs Sales Market Share by Type (2017-2028)
Figure 44. North America Human Growth Hormone Drugs Sales Market Share by Application (2017-2028)
Figure 45. North America Human Growth Hormone Drugs Sales Market Share by Country (2017-2028)
Figure 46. North America Human Growth Hormone Drugs Revenue Market Share by Country (2017-2028)
Figure 47. United States Human Growth Hormone Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Canada Human Growth Hormone Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Mexico Human Growth Hormone Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Europe Human Growth Hormone Drugs Sales Market Share by Type (2017-2028)
Figure 51. Europe Human Growth Hormone Drugs Sales Market Share by Application (2017-2028)
Figure 52. Europe Human Growth Hormone Drugs Sales Market Share by Country (2017-2028)
Figure 53. Europe Human Growth Hormone Drugs Revenue Market Share by Country (2017-2028)
Figure 54. Germany Human Growth Hormone Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. France Human Growth Hormone Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. United Kingdom Human Growth Hormone Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Russia Human Growth Hormone Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Italy Human Growth Hormone Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Asia-Pacific Human Growth Hormone Drugs Sales Market Share by Region (2017-2028)
Figure 60. Asia-Pacific Human Growth Hormone Drugs Sales Market Share by Application (2017-2028)
Figure 61. Asia-Pacific Human Growth Hormone Drugs Sales Market Share by Region (2017-2028)
Figure 62. Asia-Pacific Human Growth Hormone Drugs Revenue Market Share by Region (2017-2028)
Figure 63. China Human Growth Hormone Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Japan Human Growth Hormone Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Korea Human Growth Hormone Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. India Human Growth Hormone Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Southeast Asia Human Growth Hormone Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Australia Human Growth Hormone Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. South America Human Growth Hormone Drugs Sales Market Share by Type (2017-2028)
Figure 70. South America Human Growth Hormone Drugs Sales Market Share by Application (2017-2028)
Figure 71. South America Human Growth Hormone Drugs Sales Market Share by Country (2017-2028)
Figure 72. South America Human Growth Hormone Drugs Revenue Market Share by Country (2017-2028)
Figure 73. Brazil Human Growth Hormone Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Argentina Human Growth Hormone Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Middle East & Africa Human Growth Hormone Drugs Sales Market Share by Type (2017-2028)
Figure 76. Middle East & Africa Human Growth Hormone Drugs Sales Market Share by Application (2017-2028)
Figure 77. Middle East & Africa Human Growth Hormone Drugs Sales Market Share by Region (2017-2028)
Figure 78. Middle East & Africa Human Growth Hormone Drugs Revenue Market Share by Region (2017-2028)
Figure 79. Turkey Human Growth Hormone Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Egypt Human Growth Hormone Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. Saudi Arabia Human Growth Hormone Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. South Africa Human Growth Hormone Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 83. Manufacturing Cost Structure Analysis of Human Growth Hormone Drugs in 2021
Figure 84. Manufacturing Process Analysis of Human Growth Hormone Drugs
Figure 85. Human Growth Hormone Drugs Industrial Chain
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
Figure 87. Methodology
Figure 88. Research Process and Data Source
Figure 1. Human Growth Hormone Drugs Picture
Figure 2. Global Human Growth Hormone Drugs Revenue Market Share by Type in 2021
Figure 3. Norditropin
Figure 4. Genotropin
Figure 5. Humatrope
Figure 6. Saizen
Figure 7. Omnitrope - the Somatropin Biosimilar
Figure 8. Somatropin Biopartners
Figure 9. Global Human Growth Hormone Drugs Revenue Market Share by Application in 2021
Figure 10. Prader-Willi Syndrome
Figure 11. Turner Syndrome
Figure 12. Short Stature Homeobox Gene
Figure 13. Small for Gestational Age
Figure 14. Chronic Renal Insufficiency
Figure 15. Short Bowel Syndrome
Figure 16. Global Human Growth Hormone Drugs Revenue, (USD Million) & (K Pcs): 2017 & 2021 & 2028
Figure 17. Global Human Growth Hormone Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 18. Global Human Growth Hormone Drugs Sales (2017-2028) & (K Pcs)
Figure 19. Global Human Growth Hormone Drugs Price (2017-2028) & (USD/Pcs)
Figure 20. Global Human Growth Hormone Drugs Production Capacity (2017-2028) & (K Pcs)
Figure 21. Global Human Growth Hormone Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 22. Human Growth Hormone Drugs Market Drivers
Figure 23. Human Growth Hormone Drugs Market Restraints
Figure 24. Human Growth Hormone Drugs Market Trends
Figure 25. Global Human Growth Hormone Drugs Sales Market Share by Manufacturer in 2021
Figure 26. Global Human Growth Hormone Drugs Revenue Market Share by Manufacturer in 2021
Figure 27. Human Growth Hormone Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 28. Top 3 Human Growth Hormone Drugs Manufacturer (Revenue) Market Share in 2021
Figure 29. Top 6 Human Growth Hormone Drugs Manufacturer (Revenue) Market Share in 2021
Figure 30. Global Human Growth Hormone Drugs Sales Market Share by Region (2017-2028)
Figure 31. Global Human Growth Hormone Drugs Revenue Market Share by Region (2017-2028)
Figure 32. North America Human Growth Hormone Drugs Revenue (2017-2028) & (USD Million)
Figure 33. Europe Human Growth Hormone Drugs Revenue (2017-2028) & (USD Million)
Figure 34. Asia-Pacific Human Growth Hormone Drugs Revenue (2017-2028) & (USD Million)
Figure 35. South America Human Growth Hormone Drugs Revenue (2017-2028) & (USD Million)
Figure 36. Middle East & Africa Human Growth Hormone Drugs Revenue (2017-2028) & (USD Million)
Figure 37. Global Human Growth Hormone Drugs Sales Market Share by Type (2017-2028)
Figure 38. Global Human Growth Hormone Drugs Revenue Market Share by Type (2017-2028)
Figure 39. Global Human Growth Hormone Drugs Price by Type (2017-2028) & (USD/Pcs)
Figure 40. Global Human Growth Hormone Drugs Sales Market Share by Application (2017-2028)
Figure 41. Global Human Growth Hormone Drugs Revenue Market Share by Application (2017-2028)
Figure 42. Global Human Growth Hormone Drugs Price by Application (2017-2028) & (USD/Pcs)
Figure 43. North America Human Growth Hormone Drugs Sales Market Share by Type (2017-2028)
Figure 44. North America Human Growth Hormone Drugs Sales Market Share by Application (2017-2028)
Figure 45. North America Human Growth Hormone Drugs Sales Market Share by Country (2017-2028)
Figure 46. North America Human Growth Hormone Drugs Revenue Market Share by Country (2017-2028)
Figure 47. United States Human Growth Hormone Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Canada Human Growth Hormone Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Mexico Human Growth Hormone Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Europe Human Growth Hormone Drugs Sales Market Share by Type (2017-2028)
Figure 51. Europe Human Growth Hormone Drugs Sales Market Share by Application (2017-2028)
Figure 52. Europe Human Growth Hormone Drugs Sales Market Share by Country (2017-2028)
Figure 53. Europe Human Growth Hormone Drugs Revenue Market Share by Country (2017-2028)
Figure 54. Germany Human Growth Hormone Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. France Human Growth Hormone Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. United Kingdom Human Growth Hormone Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Russia Human Growth Hormone Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Italy Human Growth Hormone Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Asia-Pacific Human Growth Hormone Drugs Sales Market Share by Region (2017-2028)
Figure 60. Asia-Pacific Human Growth Hormone Drugs Sales Market Share by Application (2017-2028)
Figure 61. Asia-Pacific Human Growth Hormone Drugs Sales Market Share by Region (2017-2028)
Figure 62. Asia-Pacific Human Growth Hormone Drugs Revenue Market Share by Region (2017-2028)
Figure 63. China Human Growth Hormone Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Japan Human Growth Hormone Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Korea Human Growth Hormone Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. India Human Growth Hormone Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Southeast Asia Human Growth Hormone Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Australia Human Growth Hormone Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. South America Human Growth Hormone Drugs Sales Market Share by Type (2017-2028)
Figure 70. South America Human Growth Hormone Drugs Sales Market Share by Application (2017-2028)
Figure 71. South America Human Growth Hormone Drugs Sales Market Share by Country (2017-2028)
Figure 72. South America Human Growth Hormone Drugs Revenue Market Share by Country (2017-2028)
Figure 73. Brazil Human Growth Hormone Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Argentina Human Growth Hormone Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Middle East & Africa Human Growth Hormone Drugs Sales Market Share by Type (2017-2028)
Figure 76. Middle East & Africa Human Growth Hormone Drugs Sales Market Share by Application (2017-2028)
Figure 77. Middle East & Africa Human Growth Hormone Drugs Sales Market Share by Region (2017-2028)
Figure 78. Middle East & Africa Human Growth Hormone Drugs Revenue Market Share by Region (2017-2028)
Figure 79. Turkey Human Growth Hormone Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Egypt Human Growth Hormone Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. Saudi Arabia Human Growth Hormone Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. South Africa Human Growth Hormone Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 83. Manufacturing Cost Structure Analysis of Human Growth Hormone Drugs in 2021
Figure 84. Manufacturing Process Analysis of Human Growth Hormone Drugs
Figure 85. Human Growth Hormone Drugs Industrial Chain
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
Figure 87. Methodology
Figure 88. Research Process and Data Source
